Pazopanib Related Compound 2
|
|
|
- CAS-Nr.
- 1226500-02-2
- Englisch Name:
- Pazopanib Related Compound 2
- Synonyma:
- Pazopanib Impurity 75;Pazopanib Related Compound;Pazopanib Related Compound 2;N2-(2-Chloropyrimidin-4-yl)-N2,N4-bis(2,3-dimethyl-2H-indazol-6-yl)pyrimidine-2,4-diamine;2,4-Pyrimidinediamine, N2-(2-chloro-4-pyrimidinyl)-N2,N4-bis(2,3-dimethyl-2H-indazol-6-yl)-;5-(bis(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide
- CBNumber:
- CB12741887
- Summenformel:
- C26H23ClN10
- Molgewicht:
- 510.98
- MOL-Datei:
- 1226500-02-2.mol
|
Pazopanib Related Compound 2 Eigenschaften
- Siedepunkt:
- 844.7±75.0 °C(Predicted)
- Dichte
- 1.45±0.1 g/cm3(Predicted)
- pka
- 2.60±0.30(Predicted)
Sicherheit
Pazopanib Related Compound 2 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
This compound is an impurity of Pazopanib (P210925). Pazopanib is an oral angiogenesis inhibitor targeting VEGFR and PDGFR.
Pazopanib Related Compound 2 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Pazopanib Related Compound 2 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 23)Lieferanten
- Pazopanib Related Compound 2
- Pazopanib Related Compound
- 2,4-Pyrimidinediamine, N2-(2-chloro-4-pyrimidinyl)-N2,N4-bis(2,3-dimethyl-2H-indazol-6-yl)-
- N2-(2-Chloropyrimidin-4-yl)-N2,N4-bis(2,3-dimethyl-2H-indazol-6-yl)pyrimidine-2,4-diamine
- Pazopanib Impurity 75
- 5-(bis(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide
- 1226500-02-2
- C26H23ClN10
